Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy

Published:2017-05-09 Issue:9 Volume:28 Page:2729-2737
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

van den Brand Jan A.J.G.,Ruggenenti Piero,Chianca Antonietta,Hofstra Julia M.,Perna Annalisa,Ruggiero Barbara,Wetzels Jack F.M.,Remuzzi Giuseppe

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference29 articles.

1. Glomerular Diseases: Membranous Nephropathy—A Modern View

2. Chapter 7: Idiopathic membranous nephropathy

3. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy

4. A Randomized, Controlled Trial of Steroids and Cyclophosphamide in Adults with Nephrotic Syndrome Caused by Idiopathic Membranous Nephropathy

5. Long-Term Outcomes in Idiopathic Membranous Nephropathy Using a Restrictive Treatment Strategy

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination therapy with rituximab and low dose cyclophosphamide and prednisone in membranous nephropathy;Kidney International Reports;2024-09

2. Future embracing: exosomes driving a revolutionary approach to the diagnosis and treatment of idiopathic membranous nephropathy;Journal of Nanobiotechnology;2024-08-08

3. Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids;Kidney Diseases;2024-07-29

4. Membranous Nephropathy: Updates on Management;Advances in Kidney Disease and Health;2024-07

5. Meta-analysis of the effects of CYP3A5*3 gene polymorphisms on tacrolimus blood concentration and effectiveness in Chinese patients with membranous nephropathy;Frontiers in Pharmacology;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3